Clinical Trials Directory

Trials / Unknown

UnknownNCT05646810

Impact of Peripheral Afferent Input on Central Neuropathic Pain

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overarching aim of this study is to investigate the contribution of peripheral afferent input to spontaneous and evoked central neuropathic pain after a spinal cord lesion or disease.

Detailed description

A key question that has been subject to longstanding debates in the field relates to the sites and mechanisms within the peripheral or central nervous system that potentially perpetuate chronic spontaneous and evoked central neuropathic pain. The investigators hypothesize that spontaneous central neuropathic pain depends on continuous, "physiological" somatosensory input from the painful body region in the periphery. Thus, spontaneous central neuropathic pain results from pathological gain control in central somatosensory networks with decreased activation thresholds for thermo- and mechanosensitive peripheral afferents.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLidocaine (10 mg/ml)Lidocaine (10 mg/ml) will be injected according to established protocols using ultrasound guidance and an aseptic technique by an experienced anesthesiologist.
DIAGNOSTIC_TESTIsotonic salineIsotonic saline will be injected according to established protocols using ultrasound guidance and an aseptic technique by an experienced anesthesiologist.

Timeline

Start date
2022-12-01
Primary completion
2023-09-30
Completion
2023-12-31
First posted
2022-12-12
Last updated
2022-12-12

Source: ClinicalTrials.gov record NCT05646810. Inclusion in this directory is not an endorsement.